Clinical Trials Logo

Clinical Trial Summary

Primary objective of this study is to assess the accuracy and precision of intracranial pressure (ICP) measurement in patients after traumatic brain injury and subarachnoid hemorrhage when using simultaneous, non-invasive measurement compared to standard, invasive, measurement.

Secondary objective: is to assess the correlation of intracranial pressure (ICP) measurement in patients after traumatic brain injury and subarachnoid hemorrhage between simultaneous, non-invasive measurement and standard, invasive,measurement

Clinical Trial Description

Currently, ICP (Intracranial Pressure) can be measured only using invasive techniques. In a previous (pilot study) a non-invasive technique for measurement of ICP was investigated (based on simultaneously measuring of ophthalmic artery (OA) blood flow parameters in the intracranial (IOA) and extracranial (EOA) segments of the OA with two-depth transcranial Doppler (TCD)). Based on the good results of the previous study, the study should be repeated in order to further validate the new method in more patients and to obtain additional insight with more measurements.

This single centre, observational comparative study shall investigate a new non-invasive ICP absolute value measurement method in patients presenting with TBI, ICH, or secondary edema after stroke or Subarachnoid Hemorrhage (SAH) compared to current standard invasive ICP monitoring methods.Suitable patients are to be recruited soonest after their referral or admission to the Department of Neurosurgery at the Kantonsspital Aarau. Measurement will be done either at the surgical Intensive Care Unit, Stroke Unit ("SIC") or Neurosurgical Intermediate Care Unit ("NCW"). All measurements will be performed on intubated and sedated patients with invasive ICP Monitoring trough an intraparenchymatous or intraventricular probe. In the same patient, several measurements will be allowed daily.

The non-invasive technique for measurement of ICP is based on simultaneously measuring of an ophthalmic artery (OA) blood flow parameters in the intracranial (IOA) and extracranial (EOA) segments of the OA with two-depth transorbital Doppler (TCD) measurements including mechanical head frame for fixation of ultrasonic transducer on the closed eye lid. ICP pressure will be measured non-invasively by using Vittamed 205® device. This device has CE marking since July 2014.

It is planned to recruit 25 patients and to collect 69 independent paired non-invasive and invasive ICP measurements during a 24 months period after study approval. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT03227354
Study type Observational
Source Kantonsspital Aarau
Contact Jenny Kienzler
Phone +41 62 838 58 72
Status Not yet recruiting
Phase N/A
Start date September 2017
Completion date September 2019

See also
  Status Clinical Trial Phase
Recruiting NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Recruiting NCT03698747 - Myelin Imaging in Concussed High School Football Players
Recruiting NCT02059941 - Managing Severe Traumatic Brain Injury (TBI) Without Intracranial Pressure Monitoring (ICP) Monitoring Guidelines N/A
Recruiting NCT03307070 - Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury N/A
Recruiting NCT02962349 - TRansfusion Strategies in Acute Brain INjured Patients N/A
Active, not recruiting NCT02339220 - The Brave Initiative: Bringing Rehabilitation to American Veterans in an Enriched Environment N/A
Completed NCT02836951 - Rapid Diagnostics for Traumatic Brain Injury (TBI) N/A
Recruiting NCT02613936 - Transcranial Direct Current Stimulation for the Treatment of Deficits After Traumatic Brain Injury N/A
Recruiting NCT03373331 - Treating Emotional Processing Impairments in Individuals With TBI N/A
Recruiting NCT02465242 - Pupillometry for the Prediction of Neurologic Outcomes in Severe Traumatic Brain Injury N/A
Active, not recruiting NCT02424656 - Alterations in the Brain's Connectome After Severe Traumatic Brain Injury
Withdrawn NCT02148367 - Effect of Recombinant Erythropoietin on Numbers of Circulating Endothelial Progenitor Cells in Subacute TBI Phase 2
Terminated NCT02218216 - TBI MR Study 3 Houston Methodist N/A
Terminated NCT02148783 - Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI Phase 2
Active, not recruiting NCT01874847 - PLAY GAME: Post-concussion Syndrome in Youth - Assessing the GABAergic Effects of Melatonin Phase 2/Phase 3
Active, not recruiting NCT01606111 - The CAPTAIN Trial: Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery Phase 4
Completed NCT01955785 - Respiratory Treatment of Patients With Moderate and Severe Traumatic Brain Injury N/A
Completed NCT02262507 - Concussion Device Audiological Measures N/A
Completed NCT01640158 - Broad-spectrum Cognitive Remediation: Effects of a Brain Plasticity-based Program in Mild Traumatic Brain Injury N/A